Jane E. Armes

8.6k total citations · 1 hit paper
100 papers, 4.6k citations indexed

About

Jane E. Armes is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jane E. Armes has authored 100 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 29 papers in Molecular Biology and 23 papers in Cancer Research. Recurrent topics in Jane E. Armes's work include HER2/EGFR in Cancer Research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Breast Cancer Treatment Studies (10 papers). Jane E. Armes is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Breast Cancer Treatment Studies (10 papers). Jane E. Armes collaborates with scholars based in Australia, United States and United Kingdom. Jane E. Armes's co-authors include Deon J. Venter, Margaret L. Hibbs, Dianne Grail, Ashley R. Dunn, David M. Tarlinton, G. S. Hodgson, Steven A. Stacker, Elena Provenzano, Melissa C. Southey and Annegret Pelchen–Matthews and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Jane E. Armes

99 papers receiving 4.5k citations

Hit Papers

Multiple defects in the immune system of Lyn-deficient mi... 1995 2026 2005 2015 1995 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane E. Armes Australia 34 1.7k 1.5k 1.1k 936 792 100 4.6k
Michael Krainer Austria 33 1.4k 0.8× 1.5k 1.0× 767 0.7× 692 0.7× 579 0.7× 106 3.5k
K. Czerwenka Austria 41 1.5k 0.9× 1.3k 0.8× 827 0.7× 646 0.7× 567 0.7× 179 4.6k
Stefania Bellone United States 41 1.8k 1.0× 2.4k 1.6× 1.4k 1.2× 761 0.8× 343 0.4× 155 5.4k
Jamie K. Teer United States 32 2.1k 1.3× 1.7k 1.1× 993 0.9× 1.1k 1.2× 848 1.1× 96 4.4k
Philippe Martiat Belgium 38 2.0k 1.2× 1.3k 0.9× 932 0.8× 1.5k 1.6× 415 0.5× 110 5.6k
Joan M. O’Brien United States 31 2.1k 1.2× 1.8k 1.2× 586 0.5× 516 0.6× 385 0.5× 130 5.3k
Giordano Nicoletti Italy 41 2.2k 1.3× 1.7k 1.1× 1.5k 1.3× 676 0.7× 679 0.9× 140 4.9k
Michael J. Difilippantonio United States 33 3.4k 2.0× 1.4k 0.9× 1.4k 1.2× 1.1k 1.2× 775 1.0× 61 5.5k
Steve E. Kalloger Canada 44 2.7k 1.6× 1.7k 1.2× 828 0.7× 1.4k 1.5× 546 0.7× 101 6.3k
Giuliana Salvatore Italy 36 2.2k 1.3× 2.0k 1.3× 459 0.4× 596 0.6× 754 1.0× 83 5.3k

Countries citing papers authored by Jane E. Armes

Since Specialization
Citations

This map shows the geographic impact of Jane E. Armes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Armes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Armes more than expected).

Fields of papers citing papers by Jane E. Armes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane E. Armes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Armes. The network helps show where Jane E. Armes may publish in the future.

Co-authorship network of co-authors of Jane E. Armes

This figure shows the co-authorship network connecting the top 25 collaborators of Jane E. Armes. A scholar is included among the top collaborators of Jane E. Armes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane E. Armes. Jane E. Armes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farshid, Gelareh, Jane E. Armes, Benjamin F. Dessauvagie, et al.. (2024). Independent Validation of a HER2-Low Focused Immunohistochemistry Scoring System for Enhanced Pathologist Precision and Consistency. Modern Pathology. 38(4). 100693–100693. 3 indexed citations
2.
Fox, Peter, et al.. (2019). Primary squamous carcinoma of breast – a rare entity: report of two cases and review of the literature. Pathology. 51(5). 529–531. 2 indexed citations
3.
Snell, Cameron, Kristen Gibbons, Christopher Pyke, et al.. (2017). Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen. Journal of Clinical Pathology. 70(11). 954–960. 8 indexed citations
4.
5.
Smith, Deborah S., Colin J.R. Stewart, Edward Clarke, et al.. (2017). ER and PR expression and survival after endometrial cancer. Gynecologic Oncology. 148(2). 258–266. 47 indexed citations
6.
Obermair, Andreas, Donal J. Brennan, Eva Baxter, et al.. (2016). Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy. QUT ePrints (Queensland University of Technology). 1 indexed citations
7.
Liu, Cheng, et al.. (2016). Ovarian Microcystic Stromal Tumor: A Rare Clinical Manifestation of Familial Adenomatous Polyposis. International Journal of Gynecological Pathology. 35(6). 561–565. 24 indexed citations
8.
Harrington, Brittney S., et al.. (2014). Targeting the cell surface protein Cdcp1 in a model of advanced ovarian cancer. International Journal of Gynecological Cancer. 24(9). 113–113. 1 indexed citations
9.
10.
Ruwanpura, Saleela M., Louise McLeod, Alistair Miller, et al.. (2011). Interleukin-6 Promotes Pulmonary Emphysema Associated with Apoptosis in Mice. American Journal of Respiratory Cell and Molecular Biology. 45(4). 720–730. 62 indexed citations
12.
Bilous, Michael, Adrienne Morey, Jane E. Armes, Margaret C. Cummings, & Glenn Francis. (2006). Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology. 38(2). 120–124. 32 indexed citations
13.
Armes, Jane E., Rohan Lourie, Melanie de Silva, et al.. (2005). Abnormalities of the RB1 Pathway in Ovarian Serous Papillary Carcinoma as Determined by Overexpression of the p16(INK4A) Protein. International Journal of Gynecological Pathology. 24(4). 363–368. 46 indexed citations
14.
Rae, James M., Susan J. Ramus, Mark Waltham, et al.. (2004). Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Queensland's institutional digital repository (The University of Queensland). 6 indexed citations
15.
Provenzano, Elena, John L. Hopper, Graham G. Giles, et al.. (2004). Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study. Pathology. 36(3). 221–229. 18 indexed citations
16.
Willis, Simon N., Anne‐Marie Hutchins, Fleur Hammet, et al.. (2003). Detailed gene copy number and RNA expression analysis of the 17q12–23 region in primary breast cancers. Genes Chromosomes and Cancer. 36(4). 382–392. 22 indexed citations
17.
Harder, Kenneth W., Linda M. Parsons, Jane E. Armes, et al.. (2001). Gain- and Loss-of-Function Lyn Mutant Mice Define a Critical Inhibitory Role for Lyn in the Myeloid Lineage. Immunity. 15(4). 603–615. 149 indexed citations
18.
Armes, Jane E., Melissa C. Southey, Sue Sturrock, et al.. (1996). Molecular Analysis in the Diagnosis of Pediatric Lymphomas. Pediatric Pathology & Laboratory Medicine. 16(3). 435–449. 6 indexed citations
19.
Pelchen–Matthews, Annegret, Jane E. Armes, Gillian M. Griffiths, & Mark Marsh. (1991). Differential endocytosis of CD4 in lymphocytic and nonlymphocytic cells.. The Journal of Experimental Medicine. 173(3). 575–587. 124 indexed citations
20.
Armes, Jane E.. (1989). A Review of Kaposi's Sarcoma. Advances in cancer research. 53. 73–87. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026